Tumor PD-L1 expression is associated with outcomes in stage III non-small cell lung cancer (NSCLC) patients treated with consolidation durvalumab

Khalid Jazieh, Mohamed Gad, Anas Saad, Wei Wei, Nathan A. Pennell